Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
MG-262 (Z-Leu-Leu-Leu-B(OH)2): Integrative Insights into Pro
2026-04-19
Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) advances proteasome inhibition research by connecting molecular action to real-time regulation of apoptosis and cell signaling. This article uniquely bridges mechanistic depth and practical protocol guidance for advanced life science workflows.
-
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-04-18
This study introduces a patient-specific gastric cancer assembloid model integrating matched tumor organoids and stromal cell subpopulations, enabling a more physiologically relevant platform for preclinical drug testing. The findings highlight the importance of tumor microenvironment complexity in modulating drug response and resistance, providing valuable insights for personalized cancer chemotherapy research.
-
Vemurafenib (PLX4032): Optimizing Melanoma Research Workflow
2026-04-17
Vemurafenib (PLX4032) delivers robust and selective inhibition of oncogenic BRAF V600E, making it a gold-standard tool for melanoma proliferation and resistance studies. This guide demystifies its integration into experimental workflows, highlights advanced assay strategies, and offers troubleshooting insights anchored in the latest multi-omics research.
-
GRA12: A Conserved Virulence Factor in Toxoplasma gondii Acr
2026-04-16
A recent in vivo CRISPR screening study identifies GRA12 as a key secreted virulence factor required for Toxoplasma gondii infection across parasite strains and diverse mouse subspecies. This work advances our understanding of host-pathogen interactions and provides a foundation for broad-spectrum anti-parasitic strategies.
-
Applied Use of Cy3-dCTP in Direct Enzymatic DNA Labeling
2026-04-15
Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) empowers researchers with robust, high-efficiency fluorescent labeling in DNA and cDNA workflows. This article translates bench research and recent innovations into actionable guidance—optimizing PCR, Nick Translation, and advanced probe labeling for maximum signal and reproducibility.
-
Heparin Sodium: Glycosaminoglycan Anticoagulant in Modern Re
2026-04-14
Heparin sodium is a gold-standard glycosaminoglycan anticoagulant, enabling precise control over coagulation assays and translational thrombosis models. Explore advanced workflow adaptations, troubleshooting, and cutting-edge delivery strategies informed by both primary research and validated protocols.
-
Decitabine (5-Aza-2'-deoxycytidine) in Cancer Epigenetics: A
2026-04-13
Decitabine (5-Aza-2'-deoxycytidine) enables precision gene reactivation for hematopoietic and solid tumor research, with proven DNA methyltransferase inhibition. Here, we outline experimental best practices, troubleshooting, and advanced applications, linking protocol design directly to translational impact.
-
CX-5461: Applied RNA Polymerase I Inhibitor Workflows in Can
2026-04-13
CX-5461 is redefining cancer research by enabling precise, selective inhibition of ribosomal RNA synthesis in solid tumor models. This article details advanced workflows, troubleshooting strategies, and key innovations based on the latest mechanistic insights, positioning CX-5461 as a benchmark RNA polymerase I inhibitor for translational studies.
-
Puerarin Drives Osteogenesis in Dental Follicle Cells via Ni
2026-04-12
This study demonstrates that puerarin enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide pathway. The reversal of these effects by the NOS inhibitor L-NMMA acetate underscores the centrality of nitric oxide signaling in dental tissue regeneration strategies.
-
Dantrolene Sodium Salt: Applied Ryanodine Receptor Antagonis
2026-04-12
Dantrolene sodium salt enables precise, calmodulin-dependent modulation of ryanodine receptor signaling, unlocking advanced control over intracellular calcium dynamics in disease modeling and genome editing. This guide delivers stepwise protocols, troubleshooting strategies, and expert insights for maximizing reproducibility and efficacy in calcium-driven assays and synthetic lethality screens.
-
Fenipentol in Pancreatic Secretion Research: Protocols & Ins
2026-04-11
Fenipentol (1-Phenyl-1-pentanol) offers researchers a robust platform for dissecting gastrointestinal physiology by modulating bile and pancreatic secretions with precision. By leveraging its distinct biochemical properties and literature-backed protocols, scientists can address complex signaling questions and optimize experimental reproducibility in both basic and applied studies.
-
EPZ5676: Precision DOT1L Inhibitor for Advanced Leukemia Res
2026-04-11
EPZ5676 transforms epigenetic oncology workflows by enabling ultra-selective DOT1L inhibition and potent H3K79 methylation blockade in MLL-rearranged leukemia models. This guide details experimental best practices, troubleshooting, and workflow optimizations to maximize the compound’s translational impact.
-
Cy3 NHS Ester (Non-Sulfonated): Atomic Facts and Workflow...
2026-04-10
Cy3 NHS ester (non-sulfonated) is a high-performance fluorescent dye for amino group labeling of proteins, peptides, and oligonucleotides, excelling in biomedical imaging. This article provides atomic, verifiable facts on its mechanism, benchmarks, and workflow integration. Cy3 NHS ester delivers consistent, sensitive detection in research applications.
-
Polybrene (Hexadimethrine Bromide) 10 mg/mL: Viral Gene T...
2026-04-09
Polybrene (Hexadimethrine Bromide) 10 mg/mL is a validated viral gene transduction enhancer that neutralizes cell surface electrostatic repulsion, increasing lentiviral and retroviral gene delivery efficiency. As supplied by APExBIO, this reagent offers reproducible results in gene therapy research, with documented stability and performance benchmarks.
-
Nystatin (Fungicidin): Polyene Antifungal Agent for Candi...
2026-04-08
Nystatin (Fungicidin) is a polyene antifungal antibiotic validated for inhibition of diverse Candida species and Aspergillus in preclinical models. As a DMSO-soluble, ergosterol-binding antifungal, it enables reproducible, quantitative screening in cell-based assays. APExBIO’s B1993 formulation offers high solubility and batch consistency for research applications.